LEO Pharma ha presentado este martes Anzupgo (delgocitinib), el primer tratamiento en España para esta enfermedad que busca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback